Clinical Significance of β-Tricalcium Phosphate and Polyphosphate for Mastoid Cavity Obliteration during Middle Ear Surgery: Human and Animal Study
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives. Mastoid obliteration is used to obliterate the mastoid cavity following a mastoidectomy or to prevent the formation of a retraction pocket. This study evaluated the effectiveness of β-tricalcium phosphate and polyphosphate (β-TPP) for mastoid obliteration in middle ear surgeries in prospective human and animal studies. Methods. Twenty patients with chronic otitis media underwent mastoid obliteration using β-TPP after a intact canal wall mastoidectomy or simple mastoidectomy. The clinical data were prospectively evaluated including: the diagnosis,temporal bone computed tomography (TBCT), otoscopic findings, pure tone audiogram, and complications. In the animal experiment, β-TPP was applied into the right bulla in five rats, and the opposite bulla was used as the control in the non-obliterated state. The skulls of five other rats were drilled out and the holes were obliterated with β-TPP. TBCT were obtained at 3, 6, and 9 months after the obliteration and histologic analysis was done at 3 and 9 months after surgery. Results. In the human study, fourteen TBCTs were obtained at 12 months after the surgery. All demonstrated no bone resorption in the obliterated mastoids. Among the 15 cases displaying retracted tympanic membranes preoperatively,11 showed no retraction, 2 showed retraction postoperatively, 1 was lost to follow-up and 1 was a case of postoperative wound infection. Among 20 cases, one case developed a postoperative infection that necessitated a second operation. Sixteen underwent ossiculoplasty; hearing improvements were obtained in 15 cases and 1 case showed decreased hearing. In the animal study, new bone formation without significant bone resorption in the radiologic and histologic findings were noted in both the skull and bulla groups. Conclusion. Although β-TPP is a foreign material having the possibility of infection, mastoid obliteration with it can be a treatment option in middle ear surgeries to prevent retraction pockets or the recurrence of diseases.
Abstract
Objectives. Mastoid obliteration is used to obliterate the mastoid cavity following a mastoidectomy or to prevent the formation of a retraction pocket. This study evaluated the effectiveness of β-tricalcium phosphate and polyphosphate (β-TPP) for mastoid obliteration in middle ear surgeries in prospective human and animal studies. Methods. Twenty patients with chronic otitis media underwent mastoid obliteration using β-TPP after a intact canal wall mastoidectomy or simple mastoidectomy. The clinical data were prospectively evaluated including: the diagnosis,temporal bone computed tomography (TBCT), otoscopic findings, pure tone audiogram, and complications. In the animal experiment, β-TPP was applied into the right bulla in five rats, and the opposite bulla was used as the control in the non-obliterated state. The skulls of five other rats were drilled out and the holes were obliterated with β-TPP. TBCT were obtained at 3, 6, and 9 months after the obliteration and histologic analysis was done at 3 and 9 months after surgery. Results. In the human study, fourteen TBCTs were obtained at 12 months after the surgery. All demonstrated no bone resorption in the obliterated mastoids. Among the 15 cases displaying retracted tympanic membranes preoperatively,11 showed no retraction, 2 showed retraction postoperatively, 1 was lost to follow-up and 1 was a case of postoperative wound infection. Among 20 cases, one case developed a postoperative infection that necessitated a second operation. Sixteen underwent ossiculoplasty; hearing improvements were obtained in 15 cases and 1 case showed decreased hearing. In the animal study, new bone formation without significant bone resorption in the radiologic and histologic findings were noted in both the skull and bulla groups. Conclusion. Although β-TPP is a foreign material having the possibility of infection, mastoid obliteration with it can be a treatment option in middle ear surgeries to prevent retraction pockets or the recurrence of diseases.
참고문헌 (28)
- Palva T, "Ear surgery and mastoid air cell system", Arch Otolaryngol, 107(2), pp.71~73 (1981)
- Lee WS, "Mastoid and epitympanic obliteration in canal wall up mastoidectomy for prevention of retraction pocket", Otol Neurotol, 26(6), pp.1107~1111 (2005)
- Palmgren O, "Long-term results of open cavity and tympanomastoid surgery of the chronic ear", Acta Otolaryngol, 88(5-6), pp.343~349 (1979)
- Merifield DO, "Obliteration of the mastoid segment: a clinical review and pilot study of various transplant materials", Ann Otol Rhinol Laryngol, 72, pp.157~190 (1963)
- Solomons NB, "Obliteration of mastoid cavities using bone pate", J Laryngol Otol, 102(9), pp.783~784 (1988)
- Lenis A, "Hydroxylapatite canal wall reconstruction in patients with otologic dilemmas", Am J Otol, 11(6), pp.411~414 (1990)
- "Committee on Hearing and Equilibrium guidelines for the evaluation of results of treatment of conductive hearing loss. American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc", Otolaryngol Head Neck Surg, 113(3), pp.186~187 (1995)
- Palva T., "Operative technique in mastoid obliteration", Acta Otolaryngol, 75(4), pp.289~290 (1973)
- Gantz BJ, "Canal wall reconstruction tympanomastoidectomy with mastoid obliteration", Laryngoscope, 115(10), pp.1734~1740 (2005)
- Shea MC Jr, "Mastoid obliteration using homogenous bone chips and autogenous bone paste", Trans Am Acad Ophthalmol Otolaryngol, 76(1), pp.160~172 (1972)
- Black B, "Mastoidectomy elimination: obliterate, reconstruct, or ablate?", Am J Otol, 19(5), pp.551~557 (1998)
- Dornhoffer JL, "Surgical modification of the difficult mastoid cavity", Otolaryngol Head Neck Surg, 120(3), pp.361~367 (1999)
- Meurman Y, "Primary reduction of a large operation cavity in radical mastoidectomy with a muscle-periosteal flap", Acta Otolaryngol, 37(3), pp.245~252 (1949)
- Palva T, "Musculoperiosteal flap in cavity obliteration: histopathological study seven years postoperatively", Arch Otolaryngol, 95(2), pp.172~177 (1972)
- Thomas Rambo JH, "Further experience with musculoplasty", AMA Arch Otolaryngol, 71(3), pp.428~436 (1960)
- 조성우, "Mastoid Obliteration with Silicone Blocks after Canal Wall Down Mastoidectomy", Clinical and Experimental Otorhinolaryngology, 5(1), pp.23~27 (2012), 대한이비인후과학회
- Minoda R, "Preliminary experience with beta-tricalcium phosphate for use in mastoid cavity obliteration after mastoidectomy", Otol Neurotol, 28(8), pp.1018~1021 (2007)
- Goldenberg RA, "Hydroxylapatite ossicular replacement prostheses: preliminary results", Laryngoscope, 100(7), pp.693~700 (1990)
- Grote JJ, "Reconstruction of the ossicular chain with hydroxyapatite implants", Ann Otol Rhinol Laryngol Suppl, 123, pp.10~12 (1986)
- Estrem SA, "Hydroxyapatite canal wall reconstruction", mastoid obliteration, 1999, pp.120(3), 345~349
- Ambard AJ, "Calcium phosphate cement: review of mechanical and biological properties", J Prosthodont, 15(5), pp.321~328 (2006)
- 이현석, "Hydroxyapatite 입자(본그로스®)를 이용한 기니픽의 유양동 폐쇄술：방사선학적, 조직학적 연구", 대한이비인후과학회지 두경부외과학, 52(1), pp.14~18 (2009), 대한이비인후과학회
- Takahashi S, "A morphological study on obliteration of the temporal dorsal bullae using hydroxyapatite granules", Am J Otol, 17(2), pp.197~199 (1996)
- Kveton JF, "Indications for hydroxyapatite cement reconstruction in lateral skull base surgery", Am J Otol, 16(4), pp.465~469 (1995)
- Mahendran S, "Mastoid obliteration with hydroxyapatite cement: the Ipswich experience", Otol Neurotol, 25(1), pp.19~21 (2004)
- Lee WS, "Canal wall reconstruction and mastoid obliteration in canal wall down tympanomastoidectomized patients", Acta Otolaryngol, 129(9), pp.955~961 (2009)
- Jin Hoon Park, "Radiographic Analysis of Instrumented Posterolateral Fusion Mass Using Mixture of Local Autologous Bone and b-TCP (PolyBone^®) in a Lumbar Spinal Fusion Surgery", 대한신경외과학회지, 49(5), pp.267~272 (2011), 대한신경외과학회
- Park YH, "Obliteration of temporal dorsal bulla in guinea pigs using different types of calcium phosphate", Int J Pediatr Otorhinolaryngol, 75(9), pp.1176~1180 (2011)